The leading representative office of defined VC is situated in the Singapore. The venture was found in Asia in Singapore.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Heritas Capital Management, startups are often financed by Lim Der Shing, Golden Gate Ventures, 500 Startups. The meaningful sponsors for the fund in investment in the same round are Seeds Capital, Bisk Ventures, Wooshin Venture Investment Corp.. In the next rounds fund is usually obtained by Wooshin Venture Investment Corp., Seeds Capital, Mirae Asset Venture Investment.
The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ReUp Education, Pathstream, Alodokter. Among the most successful fund investment fields, there are Education, Consulting.
We also calculated 4 valuable employees in our database.
The fund is generally included in 2-6 deals every year. The high activity for fund was in 2019. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars.
|Arnel Capital Management||-|
|Biossom Investment Management||Beijing, Beijing, China|
|Blackfin Technology||Boise, Idaho, United States|
|Breakaway Solutions||Boston, Massachusetts, United States|
|Catholic Health Initiatives||Colorado, Englewood, United States|
|Ceres Venture Fund||Evanston, Illinois, United States|
|Chan Brothers Group||Central, Central Region, Singapore|
|Fang Group||Chaoyang, China, Liaoning|
|Four Rivers Group||California, San Francisco, United States|
|HSBC Equipment Finance UK Ltd||Birmingham, England, United Kingdom|
|Huaqiang Asset Management Group||China, Guangdong, Shenzhen|
|Meyer Equity||New York, New York, United States|
|Prairie Capital||Chicago, Illinois, United States|
|Prisma Energy International||Houston, Texas, United States|
|Yeoman's Capital||Austin, Texas, United States|
|ZJ Innopark (Zhangjiang Hi-Tech Park)||China, Shanghai|
|$3M||28 Apr 2022||Singapore, Central Region, Singapore|
|$20M||12 Jan 2022||Vietnam, Ho Chi Minh City, Vietnam|
|$10M||09 Dec 2021||Jakarta, Jakarta Raya, Indonesia|
|06 Dec 2021||Singapore, Central, Singapore|
|$7M||23 Nov 2021||Jakarta Pusat, Jakarta Raya, Indonesia|
|$5M||19 Oct 2021||Noida, Uttar Pradesh, India|
|$46M||31 Aug 2021||Bengaluru, Karnataka, India|
|$125M||18 May 2021||Singapore, Central Region, Singapore|
|$16M||18 Jan 2021||Bengaluru, Karnataka, India|
– Hummingbird Bioscience from Singapore develops precision therapies against hard-to-drug targets to improve treatment outcomes.
– Series C $125m round brings company valuation to more than $1b.
– The round was led by Novo Holdings with participation from new investors – Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, DROIA Ventures, Morningside Ventures, Pureos Bioventures, Polaris Partners, Affinity Asset Advisors, Ally Bridge Group and Altrium Capital Management and existing investors SK Inc, Heritas Capital, and Mirae Asset Venture Capital.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.